Common symptoms of PTSD include recurring recollections and dreams related to the traumatic event, avoidance and numbing, and hypervigilance. Recent reviews have consistently recommended trauma-focused psychological therapies as a first-line treatment for PTSD, although pharmacological treatments have also been found to be effective in some cases.
This module introduced the different biological, psychological and social models of PTSD in adults. It also provided up-to-date information on the epidemiology of PTSD and outlined steps to help prevent and treat the condition.
Models of PTSD
▪ PTSD is a psychiatric disorder characterised by re-experiencing, avoidance, numbing of responsiveness and hyperarousal.
▪ Classical conditioning was the original psychological theory of PTSD.
▪ Recently, the cognitive model of negative appraisals and overgeneralisation has had great influence.
▪ The amygdala, hippocampus and medial prefrontal cortex are believed to be involved in PTSD.
▪ Low cortisol levels have been linked to PTSD, although other neurotransmitters are thought to be involved.
Epidemiology, prognosis and prevention
▪ Experience of PTSD symptoms straight after traumatic events is common (but does not necessarily indicate that a disorder is present as symptoms often fade away).
▪ The lifetime prevalence for PTSD is thought to be around 6.8%, and 12-month prevalence 3.5%.
▪ There is a high comorbidity rate of around 80%.
▪ Formal single-session interventions aimed at preventing PTSD should not be given following trauma.
Treatment
▪ Trauma-focused cognitive-behavioural therapy (TFCBT) has been shown to be effective for those suffering from acute stress disorder or acute PTSD within three months of a traumatic event.
▪ TFCBT and eye movement desensitisation and reprocessing (EMDR) have been shown to be effective for chronic PTSD. A phased approach (STAIR-MPE) and narrative exposure therapy (NET) should also be considered especially with more complex presentations.
▪ There are conflicting recommendations for pharmacological treatment.
▪ Direct comparisons between psychological and pharmacological treatments are not yet available ▪ 8-12 sessions of TFCBT or EMDR are recommended in the NICE guideline (although there is some evidence that longer treatment is helpful), with medication given as a second-line treatment or reflecting patient choice.
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